Cited by 70Extracellular vesicles in diseaseNanoparticle-Based Drug DeliveryMesenchymal stem cell research

Circulating exosomes in cardiovascular disease: Novel carriers of biological information

Open access
Liu, Qing, Piao, Hulin, Wang, Yong, Zheng, Dongdong, Wang, Weitie·2021·Biomedicine & Pharmacotherapy

Abstract

Exosomes are a group of nanosized extracellular vesicles that include various bioactive nucleic acids, lipids, and proteins. They originate from membrane invagination and are released by exocytosis, which can transmit signals to target cells to achieve cell-to-cell communication and maintain homeostasis. The heart is a complex multicellular organ that contains resident cell types such as fibroblasts, endothelial cells, and smooth muscle cells. Communication between different cell types and immune systems is essential for the dynamic equilibrium of the cardiac internal environment. Intercellular communication is a universal phenomenon mediated by exosomes and their contents during several pathological processes in cardiovascular diseases, such as cardiomyocyte hypertrophy, apoptosis, and angiogenesis. Therefore, exosomes can be used as novel invasive diagnostic biomarkers in multiple diseases, including atherosclerosis, myocardial ischemia, cardiac fibrosis, and ischemia-reperfusion injury. In addition, the biocompatible nature and low immunogenicity of exosomes make them high-quality nanoparticle drug carriers with potential applications in translational medicine and therapeutic strategies. Here, we focus on the biogenesis, isolation, biological functions, and future application prospects of exosomes in cardiovascular disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biopha.2020.111148

Cites

160 of 160 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

2 retracted

Flagged first, then by citations

Research works printed but not linked: 1

  1. D.J. Cha, J.L. Franklin, Y. Dou, Q. Liu, J.N. Higginbotham, Demory, et al., KRAS- dependent sorting of miRNA to exosomes. eLife. 4 (2015), e07197.

Cited by

Sorted by citations

Authors
Liu, Q., Piao, H., Wang, Y., Zheng, D., & Wang, W.
Affiliations
  • The University of Tokyo (JP)
  • Jilin University (CN)
Corresponding author
Wang, Weitie
Venue
Biomedicine & Pharmacotherapy
Publisher
Elsevier BV
Published
2021-03
Volume
135
Pages
111148
ISSN
0753-3322 (ISSN-L)
OpenAlex
W3121001442
Cited by
70
References
160
Citations by year
2026: 9 · 2025: 13 · 2024: 13 · 2023: 15 · 2022: 11 · 2021: 9
FWCI
1.26
Type
journal article
Language
en
Open access
Locations
  • Biomedicine & Pharmacotherapy (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (81970399)
  • Department of Science and Technology of Jilin Province (20190901008JC)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
Keywords
exosomes, extracellular vesicles, cardiovascular disease, intercellular communication, exosome biogenesis, exosome isolation, exosomal biomarkers, atherosclerosis, myocardial ischemia, myocardial fibrosis, ischemia-reperfusion injury, cardiomyocyte hypertrophy, angiogenesis, nanomedicine
MeSH terms
Animals, Cardiovascular Diseases, Cardiovascular System, Cell Communication, Drug Carriers, Humans, Genetic Therapy, Signal Transduction, Biomarkers, Gene Transfer Techniques, Exosomes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review